282 related articles for article (PubMed ID: 11085506)
1. Threonine 68 phosphorylation by ataxia telangiectasia mutated is required for efficient activation of Chk2 in response to ionizing radiation.
Ahn JY; Schwarz JK; Piwnica-Worms H; Canman CE
Cancer Res; 2000 Nov; 60(21):5934-6. PubMed ID: 11085506
[TBL] [Abstract][Full Text] [Related]
2. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.
Matsuoka S; Rotman G; Ogawa A; Shiloh Y; Tamai K; Elledge SJ
Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10389-94. PubMed ID: 10973490
[TBL] [Abstract][Full Text] [Related]
3. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
[TBL] [Abstract][Full Text] [Related]
4. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
5. Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1.
Melchionna R; Chen XB; Blasina A; McGowan CH
Nat Cell Biol; 2000 Oct; 2(10):762-5. PubMed ID: 11025670
[TBL] [Abstract][Full Text] [Related]
6. The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis.
Falck J; Mailand N; Syljuåsen RG; Bartek J; Lukas J
Nature; 2001 Apr; 410(6830):842-7. PubMed ID: 11298456
[TBL] [Abstract][Full Text] [Related]
7. Chk2 activation and phosphorylation-dependent oligomerization.
Xu X; Tsvetkov LM; Stern DF
Mol Cell Biol; 2002 Jun; 22(12):4419-32. PubMed ID: 12024051
[TBL] [Abstract][Full Text] [Related]
8. Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway.
Chaturvedi P; Eng WK; Zhu Y; Mattern MR; Mishra R; Hurle MR; Zhang X; Annan RS; Lu Q; Faucette LF; Scott GF; Li X; Carr SA; Johnson RK; Winkler JD; Zhou BB
Oncogene; 1999 Jul; 18(28):4047-54. PubMed ID: 10435585
[TBL] [Abstract][Full Text] [Related]
9. DNA damage-induced cell cycle regulation and function of novel Chk2 phosphoresidues.
Buscemi G; Carlessi L; Zannini L; Lisanti S; Fontanella E; Canevari S; Delia D
Mol Cell Biol; 2006 Nov; 26(21):7832-45. PubMed ID: 16940182
[TBL] [Abstract][Full Text] [Related]
10. The mismatch repair system is required for S-phase checkpoint activation.
Brown KD; Rathi A; Kamath R; Beardsley DI; Zhan Q; Mannino JL; Baskaran R
Nat Genet; 2003 Jan; 33(1):80-4. PubMed ID: 12447371
[TBL] [Abstract][Full Text] [Related]
11. Ionizing radiation induces ataxia telangiectasia mutated kinase (ATM)-mediated phosphorylation of LKB1/STK11 at Thr-366.
Sapkota GP; Deak M; Kieloch A; Morrice N; Goodarzi AA; Smythe C; Shiloh Y; Lees-Miller SP; Alessi DR
Biochem J; 2002 Dec; 368(Pt 2):507-16. PubMed ID: 12234250
[TBL] [Abstract][Full Text] [Related]
12. The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation.
Lee CH; Chung JH
J Biol Chem; 2001 Aug; 276(32):30537-41. PubMed ID: 11390408
[TBL] [Abstract][Full Text] [Related]
13. A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage.
Carlessi L; Buscemi G; Fontanella E; Delia D
Biochim Biophys Acta; 2010 Oct; 1803(10):1213-23. PubMed ID: 20599567
[TBL] [Abstract][Full Text] [Related]
14. The Wip1 phosphatase (PPM1D) antagonizes activation of the Chk2 tumour suppressor kinase.
Oliva-Trastoy M; Berthonaud V; Chevalier A; Ducrot C; Marsolier-Kergoat MC; Mann C; Leteurtre F
Oncogene; 2007 Mar; 26(10):1449-58. PubMed ID: 16936775
[TBL] [Abstract][Full Text] [Related]
15. Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2.
Carlessi L; Buscemi G; Larson G; Hong Z; Wu JZ; Delia D
Mol Cancer Ther; 2007 Mar; 6(3):935-44. PubMed ID: 17363488
[TBL] [Abstract][Full Text] [Related]
16. Purification and characterization of ATM from human placenta. A manganese-dependent, wortmannin-sensitive serine/threonine protein kinase.
Chan DW; Son SC; Block W; Ye R; Khanna KK; Wold MS; Douglas P; Goodarzi AA; Pelley J; Taya Y; Lavin MF; Lees-Miller SP
J Biol Chem; 2000 Mar; 275(11):7803-10. PubMed ID: 10713094
[TBL] [Abstract][Full Text] [Related]
17. Role of human Cds1 (Chk2) kinase in DNA damage checkpoint and its regulation by p53.
Tominaga K; Morisaki H; Kaneko Y; Fujimoto A; Tanaka T; Ohtsubo M; Hirai M; Okayama H; Ikeda K; Nakanishi M
J Biol Chem; 1999 Oct; 274(44):31463-7. PubMed ID: 10531348
[TBL] [Abstract][Full Text] [Related]
18. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.
Matsuoka S; Huang M; Elledge SJ
Science; 1998 Dec; 282(5395):1893-7. PubMed ID: 9836640
[TBL] [Abstract][Full Text] [Related]
19. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity.
Zhou BB; Chaturvedi P; Spring K; Scott SP; Johanson RA; Mishra R; Mattern MR; Winkler JD; Khanna KK
J Biol Chem; 2000 Apr; 275(14):10342-8. PubMed ID: 10744722
[TBL] [Abstract][Full Text] [Related]
20. Loss of RPA1 induces Chk2 phosphorylation through a caffeine-sensitive pathway.
Araya R; Hirai I; Meyerkord CL; Wang HG
FEBS Lett; 2005 Jan; 579(1):157-61. PubMed ID: 15620706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
